EMA Authorised: Zinforo (ceftaroline fosamil) — Pfizer Ireland Pharmaceuticals

View source ↗

Summary

The EMA authorised Zinforo (ceftaroline fosamil) for community-acquired infections, including pneumonia and skin and soft tissue infections, with Pfizer Ireland…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Community-acquired Pneumonia
• Skin and Soft Tissue Infections

Drugs mentioned

• Zinforo (ceftaroline fosamil)

Snippet

Status: Authorised. Therapeutic area: Community-Acquired Infections;Skin Diseases, Infectious;Pneumonia. MAH: Pfizer Ireland Pharmaceuticals. Decision date: 14/08/2025